Tacoma Motor Vehicle Accident Attorney
Olympia Personal Injury Lawyer
Tacoma Wrongful Death Lawyer
Olympia Bad Faith Insurance Lawyer
Olympia Nursing Home Abuse Lawyer
Olympia Motorcycle Accident Lawyer
Olympia Personal Injury Attorney Other Practice Areas
Tacoma Personal Injury Law Offices
Personal Injury Law Offices in Olympia

Washington Personal Injury Statute of Limitations
Tacoma Personal Injury Dictionary of Legal Terms
Washington Government Resources
Tacoma Personal Injury Lawyers Our Tacoma, Olympia Attorney Biographies Contact Information: Tacoma, Olympia Personal Injury Lawyers Sign up for our Newsletter: Tacoma, Olympia Personal Injury Lawyers

March 4, 2009 - US Court Ruling Exposes Drugmakers to Lawsuits Over Warning Labels

The US Supreme Court ruled Wednesday that patients can sue drugmakers for failing to warn adequately of serious side effects, even if their warning labels were approved by the federal government, according to a landmark case that could expose the industry to billions of dollars in damages.

In a 6-3 decision, the court upheld a 7-million-dollar reward to a professional musician whose arm had to be amputated after she was improperly injected with Phenergan, an anti-nausea drug produced by pharmaceutical firm Wyeth.

The ruling opens the door for thousands of pending lawsuits - worth billions of dollars - by patients against Wyeth and other pharmaceutical companies over inadequate warnings about their products.

Diana Levine had already settled a lawsuit against the hospital that injected her improperly, causing the loss of her arm and her livelihood as a musician. But she also alleged that while Wyeth warned of the dangerous risks in using Phenergan, it failed to instruct physicians on the safest method of administering the drug.

Wyeth had argued that its warnings were approved by the US Food and Drug Administration, the US federal regulator. But Justice John Paul Stevens, writing for the court, said it was up to the drugmakers to go above and beyond the FDA's own judgements.

"The FDA has limited resources to monitor the 11,000 drugs on the market, and manufacturers have superior access to information about their drugs, especially in the post-marketing phase as new risks emerge," Stevens wrote.

<< back

The above is not legal advice. That can only come from a qualified attorney who is familiar with all the facts and circumstances of a particular, specific case and the relevant law. See Terms of Use.

The law firm of Harold D. Carr is not responsible for information contained in any links to other websites from this site. Links are provided for educational information only and may not apply to your specific circumstance. It is possible for information on other links to be inaccurate or misleading. You are cautioned to exercise extreme care when using any resource link. For specific legal advice regarding your specific case contact the law firm of Harold D. Carr at 1 800 700 8082.

Tacoma Personal Injury Lawyer, Harold D. Carr

Free Olympia & Tacoma Personal Injury Case Review

Motor Vehicle Crash Reconstruction Videos